Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
13.59
0.00 (0.00%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $178.64 million as of October 24, 2024. Its market cap has increased by 49.61% in one year.
Market Cap
178.64M
Enterprise Value
171.41M
1-Year Change
49.61%
Ranking
Category
Stock Price
$13.59
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $178.64M, an increase of 160.07%. That is a compound annual growth rate of 26.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 178.60M | 32.10% |
| Dec 29, 2023 | 135.20M | -30.77% |
| Dec 30, 2022 | 195.30M | -38.83% |
| Dec 31, 2021 | 319.30M | -27.15% |
| Dec 31, 2020 | 438.30M | 538.10% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TruBridge | 183.11M |
| Candel Therapeutics | 182.72M |
| Nevro | 182.69M |
| MediWound | 181.10M |
| Sagimet Biosciences | 179.99M |
| Profound Medical | 178.24M |
| Vaxart | 177.24M |
| Accuray | 175.48M |